Please upgrade your browser.
Genentech announces that Avastin (bevacizumab) has been granted approval by the FDA, in combination with interferon alfa therapy, for the treatment of patients with metastatic renal cell carcinoma.
Prostate Cancer Surgeon David B. Samadi, MD Discusses Importance of Surgical Experience in Robotic Surgery on Channel
Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival - Abstract
|Powered by NeonCRM|